At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 122 enrolled
Drug / intervention
ABT-712 Extended-release +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Multicenter, Single-blind, Placebo-controlled Study Comparing the Analgesic Efficacy and Safety of Hydrocodone/ Acetaminophen Extended-release Tablets and Hydrocodone/Acetaminophen (NORCO) to Placebo in Subjects With Acute Pain Following Third Molar Tooth Extraction
In Brief
A Phase 2 clinical trial evaluating ABT-712 Extended-release, Hydrocodone/Acetaminophen Immediate-release, and 1 other intervention for Pain. Completed, enrolled 122 participants across 3 sites.
Detailed Summary
The purpose of this study was to evaluate analgesic efficacy and safety of hydrocodone/acetaminophen compared to placebo in moderate to severe pain following molar extraction.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJun 2009
First PostedJul 2009
Primary CompletionAug 2009
TodayJul 2026
First PostedJul 9, 2009
Enrollment StartJun 1, 2009
Primary CompletionAug 1, 2009
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 17.0 years ago
Interventions
ABT-712 Extended-releasedrug
ABT-712 extended-release tablet
Hydrocodone/Acetaminophen Immediate-releasedrug
Hydrocodone/acetaminophen immediate-release tablet
Placebodrug
Placebo tablet